Anzeige
Mehr »
Login
Freitag, 04.12.2020 Börsentäglich über 12.000 News von 648 internationalen Medien
+++Übernahmekampf: Hammer-Nachricht bei unserem Nevada-Goldwert+++
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoAs COVID demand surges, BD blueprints $1.2B expansion to jack up prefilled syringe output by 50%
DoNot just AstraZeneca: Hackers targeted 5 other COVID drug developers, vaccine cold chain suppliers
DoAnthony Fauci slams U.K.'s speedy review of Pfizer, BioNTech COVID shot
DoHow can the $23B market for PD-1 blockers grow? 'Pan-adjuvant' use is key: report
DoBiohaven revs up migraine med Nurtec ODT with NASCAR sponsorship
DoJSR's CDMO arm plans $150M biologics facility in Research Triangle alongside unnamed pharma partner
DoPharma payments to physicians still deliver a big 'return on investment' in prescription growth, study finds
MiRoche, Blueprint catches up with Lilly as Gavreto snags FDA thyroid cancer nod
MiCDMO Sterling plots buyout of antibody-drug conjugate specialist in play at next-gen oncology market
MiMerck spotlights cancer survivorship in first podcast series featuring patients and loved ones
MiLonza plots 2 manufacturing suites for antibody-drug conjugates at Switzerland site
MiMerck cashes in on Moderna COVID-19 vaccine enthusiasm with sale of equity stake
MiThe $38B pie: Pfizer, Moderna COVID-19 vaccines set for lion's share of 2021 sales
MiPfizer, BioNTech nabs COVID vaccine authorization from UK for first-ever marketed mRNA shot
DiHalozyme scores $190M Horizon deal to develop subQ Tepezza formula
DiWhy isn't Pfizer's COVID vaccine OK'd yet? White House calls in FDA chief Hahn to explain: Axios
DiAmgen, Takeda and UCB join forces in new COVID-19 drug repurposing study
DiIndivior faces lawsuit from ex-parent company RB over Suboxone marketing scheme
DiFDA goes beyond the label to educate doctors-and enlighten others-about new cancer drugs
DiAstraZeneca hands European Crestor rights to old customer Grünenthal for $350M
MoAstraZeneca staffers targeted in suspected hacking scheme amid work on COVID vaccine: report
MoRevance's frown-line injection latest to face regulatory delay after FDA can't hit inspection deadline
MoMcKinsey consultants proposed Purdue offer rebates for opioid overdoses: NYT
MoBoehringer Ingelheim features Queen Latifah, Bernie Williams in new lung disease documentary
MoSigned, sealed, delivered: Pfizer marks 1st 'mass air shipment' of COVID-19 shot amid cold-chain scrutiny